Filing Details

Accession Number:
0001127602-20-029950
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-24 17:49:10
Reporting Period:
2020-11-23
Accepted Time:
2020-11-24 17:49:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
816956 Conmed Corp CNMD Electromedical & Electrotherapeutic Apparatus (3845) 160977505
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1741585 Marie Johonna Pelletier C/O Conmed Corporation
525 French Road
Utica NY 13502
Treasurer And Vp, Tax No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-23 7,600 $39.87 11,481 No 4 M Direct
Common Stock Disposition 2020-11-23 7,600 $103.40 3,881 No 4 S Direct
Common Stock Acquisiton 2020-11-23 3,000 $41.93 6,881 No 4 M Direct
Common Stock Disposition 2020-11-23 3,000 $103.21 3,881 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options To Purchase Common Stock Disposition 2020-11-23 7,600 $0.00 7,600 $39.87
Common Stock Options To Purchase Common Stock Disposition 2020-11-23 3,000 $0.00 3,000 $41.93
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,900 2026-03-01 No 4 M Direct
7,000 2027-03-01 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.17 to $103.44. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.13 to $103.27. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
  3. The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period